These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8077992)

  • 1. The in vitro activity of FCE 22101 against gram-negative aerobic isolates resistant to third generation cephalosporins.
    Voutsinas D; Galanakis N; Giamarellou H
    J Chemother; 1994 Apr; 6(2):99-101. PubMed ID: 8077992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
    Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
    J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli.
    Chong Y; Lee K; Kwon OH
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():21-9. PubMed ID: 8150765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.
    Barry AL; Jones RN; Thornsberry C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():17-30. PubMed ID: 2732139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
    Jean SS; Teng LJ; Hsueh PR; Ho SW; Luh KT
    J Antimicrob Chemother; 2002 Jan; 49(1):69-76. PubMed ID: 11751769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of cefepime and cefpirome compared to other third-generation cephem antibiotics against gram-negative nosocomial pathogens.
    Tumah HN
    Pharmazie; 2004 Nov; 59(11):854-8. PubMed ID: 15587586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of new cephalosporins against multi-resistant gram-negative bacteria.
    Fainstein V; Le Blanc B; Bodey GP
    Infection; 1983; 11 Suppl 1():S20-2. PubMed ID: 6832840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro interactions of FCE 22101 with aminoglycosides against gram-negative rods.
    Said AA; Livermore DM
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():103-8. PubMed ID: 2732132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro comparison of ceftazidime and nine other antimicrobial agents against hospital strains of Gram-negative bacteria.
    Wilkinson LD; Gentry LO
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():53-6. PubMed ID: 19802969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
    Ergova R; K'oleian E; Kharalambieva Ia; Mitov I; Docheva Iu
    Vutr Boles; 2000; 32(1):13-7. PubMed ID: 11195191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates.
    Dornbusch K; Kronvall G; Göransson E; Mörtsell E
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():43-52. PubMed ID: 2732143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
    Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)].
    Sidorenko SV; Strachunskiĭ LS; Akhmedova LI; Beloborodov VB; Bogomolova NS; Bol'shakov LV; Dekhnich AV; Karabak VI; Malikov VE; Pavlova MV; Polikarpova SV; Rudnov VA; Iakovlev VP
    Antibiot Khimioter; 1999; 44(11):7-16. PubMed ID: 10629736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
    Rossi R; Castellani P; Younes G; Della Bruna C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolates.
    Barclay CA; Iribarren MA; Goldberg M; Traballi CA; Casellas JM
    Chemotherapy; 1987; 33(3):165-71. PubMed ID: 3595259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.